RIC biologics is part of the RIC group, a privately-owned European center of excellence in the field of analytics. The company was founded by Professor Pat Sandra over 35 years ago and is
now headed by his two sons, Tom Sandra and Koen Sandra.

Working closely with our pharma customers for many years we have experienced first-hand how profound product understanding is a critical attribute for success. However, obtaining this analytical insight is a continuous process and its scope evolves throughout development.

Driven by our passion for analytics we can support you through all phases of your product’s lifecycle: from early lead selection, throughout clinical research and during your commercial activities.

As a state-of-the art, flexible extension of your in-house capabilities, our involvement creates an effective learning platform and ensures you have the right analytical tools and data available at the right time.